{"title":"翻开2016年。","authors":"Markus Dettenhofer, Winston Patrick Kuo","doi":"10.5772/62174","DOIUrl":null,"url":null,"abstract":"<p><p>As we conclude another year (2015), Volume 2 completed, we are pleased with the number of quality published manuscripts. We are also excited to announce Nanobiomedicine has been indexed in DOAJ (Directory of Open Access Journals) (https://doaj.org/toc/1849-5435)! This was in part attributed with the help of our Special Editor, Dr. Barbara Smith, who spearheaded manuscripts highlighting innovative results that impacted the global health spectrum implementing new methods for disease diagnosis, including technological and product development for enhanced point-of-care and personalized health care. Dr. Smith undertook this endeavor as she transitioned from a post-doc position (from George Whitesides' lab at Harvard University) to a faculty position at Arizona State, getting acclimated and setting up her laboratory. We want to thank Dr. Smith for her time and commitment to our journal. It's worth noting, we had a high number of submissions throughout the year, however, the expectations of the manuscripts not published fell short due to our review process, indicating the emphasis of publishing high quality manuscripts. We thank all the reviewers for their time and feedback.</p>","PeriodicalId":56366,"journal":{"name":"Nanobiomedicine","volume":"2 ","pages":"11"},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5772/62174","citationCount":"0","resultStr":"{\"title\":\"Turning the Page to Year 2016.\",\"authors\":\"Markus Dettenhofer, Winston Patrick Kuo\",\"doi\":\"10.5772/62174\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>As we conclude another year (2015), Volume 2 completed, we are pleased with the number of quality published manuscripts. We are also excited to announce Nanobiomedicine has been indexed in DOAJ (Directory of Open Access Journals) (https://doaj.org/toc/1849-5435)! This was in part attributed with the help of our Special Editor, Dr. Barbara Smith, who spearheaded manuscripts highlighting innovative results that impacted the global health spectrum implementing new methods for disease diagnosis, including technological and product development for enhanced point-of-care and personalized health care. Dr. Smith undertook this endeavor as she transitioned from a post-doc position (from George Whitesides' lab at Harvard University) to a faculty position at Arizona State, getting acclimated and setting up her laboratory. We want to thank Dr. Smith for her time and commitment to our journal. It's worth noting, we had a high number of submissions throughout the year, however, the expectations of the manuscripts not published fell short due to our review process, indicating the emphasis of publishing high quality manuscripts. We thank all the reviewers for their time and feedback.</p>\",\"PeriodicalId\":56366,\"journal\":{\"name\":\"Nanobiomedicine\",\"volume\":\"2 \",\"pages\":\"11\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.5772/62174\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nanobiomedicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5772/62174\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Engineering\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanobiomedicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/62174","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Engineering","Score":null,"Total":0}
As we conclude another year (2015), Volume 2 completed, we are pleased with the number of quality published manuscripts. We are also excited to announce Nanobiomedicine has been indexed in DOAJ (Directory of Open Access Journals) (https://doaj.org/toc/1849-5435)! This was in part attributed with the help of our Special Editor, Dr. Barbara Smith, who spearheaded manuscripts highlighting innovative results that impacted the global health spectrum implementing new methods for disease diagnosis, including technological and product development for enhanced point-of-care and personalized health care. Dr. Smith undertook this endeavor as she transitioned from a post-doc position (from George Whitesides' lab at Harvard University) to a faculty position at Arizona State, getting acclimated and setting up her laboratory. We want to thank Dr. Smith for her time and commitment to our journal. It's worth noting, we had a high number of submissions throughout the year, however, the expectations of the manuscripts not published fell short due to our review process, indicating the emphasis of publishing high quality manuscripts. We thank all the reviewers for their time and feedback.
NanobiomedicineBiochemistry, Genetics and Molecular Biology-Biotechnology
CiteScore
6.80
自引率
0.00%
发文量
1
审稿时长
14 weeks
期刊介绍:
Nanobiomedicine is an international, peer-reviewed, open access scientific journal that publishes research in nanotechnology as it interfaces with fundamental studies in biology, as well as its application to the fields of medicine. Nanobiomedicine covers all key aspects of this research field, including, but not limited to, bioengineering, biophysics, physical and biological chemistry, and physiology, as well as nanotechnological applications in diagnostics, therapeutic application, preventive medicine, drug delivery, and monitoring of human disease. Additionally, theoretical and modeling studies covering the nanobiomedicine fields will be considered. All submitted articles considered suitable for Nanobiomedicine are subjected to rigorous peer review to ensure the highest levels of quality. The review process is carried out as quickly as possible to minimize any delays in the online publication of articles. Submissions are encouraged on all topics related to nanobiomedicine, and its clinical applications including but not limited to: Nanoscale-structured biomaterials, Nanoscale bio-devices, Nanoscale imaging, Nanoscale drug delivery, Nanobiotechnology, Nanorobotics, Nanotoxicology, Nanoparticles, Nanocarriers, Nanofluidics, Nanosensors (nanowires, nanophotonics), Nanosurgery (dermatology, gastroenterology, ophthalmology, etc), Nanocarriers commercialization of nanobiomedical technologies, Market trends in the nanobiomedicine space, Ethics and regulatory aspects of nanobiomedicine approval, New perspectives of nanobiomedicine in clinical diagnostics, BioMEMS, Nano-coatings, Plasmonics, Nanoscale visualization.